BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29504963)

  • 21. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer.
    Ahn BC; Lee SW; Lee J; Kim C
    Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
    Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
    J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel use of
    Parihar AS; Sood A; Kumar R; Bhusari P; Shukla J; Mittal BR
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1836-1837. PubMed ID: 29713764
    [No Abstract]   [Full Text] [Related]  

  • 24. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-positive 131I uptake by the temporomandibular joint effusion.
    Zhang M; Zhang Y; Huang W; Li B
    Clin Nucl Med; 2013 Oct; 38(10):823-5. PubMed ID: 24107815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K; Hay JH; Wilson DC
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
    Thientunyakit T
    Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
    Mugunthan N; Kumar AR; Thomas P
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SSO thyroid cancer guidelines questioned.
    Neal M
    Oncology (Williston Park); 1997 Dec; 11(12):1772, 1775. PubMed ID: 9436182
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
    Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
    Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
    Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar metastasis of papillary thyroid carcinoma detected with somatostatin receptor scintigraphy.
    Czepczyński R; Wyszomirska A; Gryczyńska M; Szczepanek-Parulska E; Ruchała M
    Endokrynol Pol; 2018; 69(1):24-27. PubMed ID: 29319129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retained esophagus uptake of iodine-131 in a patient with papillary thyroid carcinoma mimicking a mediastinal mass.
    Kurtaran A; Ozer S; Kienast O; Dobrozemsky G; Dudczak R
    Thyroid; 2003 Feb; 13(2):225. PubMed ID: 12699600
    [No Abstract]   [Full Text] [Related]  

  • 35. False positive uptake in post-treatment iodine-131 whole-body scans secondary to contamination.
    Schlosser J; Paliou M; Bravo-Vera R; Sheikh A; Gouller A
    Thyroid; 2007 Jan; 17(1):81-2. PubMed ID: 17274756
    [No Abstract]   [Full Text] [Related]  

  • 36. 123I accumulation in thoracic neoesophagus masking residual papillary thyroid cancer.
    Jackson T; Sabbah N; Iagaru A
    Clin Nucl Med; 2015 Feb; 40(2):e150-1. PubMed ID: 24999691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma.
    Nahas Z; Goldenberg D; Fakhry C; Ewertz M; Zeiger M; Ladenson PW; Wahl R; Tufano RP
    Laryngoscope; 2005 Feb; 115(2):237-43. PubMed ID: 15689742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An unusual case of a false-positive iodine-131 whole body scan in a patient with papillary thyroid cancer.
    Ceccarelli C; Pacini F; Lippi F; Pinchera A
    Clin Nucl Med; 1988 Mar; 13(3):192-3. PubMed ID: 3289821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive uptake on radioiodine whole-body scan due to bronchiectasis.
    Espírito Santo R; Marques P; João Bugalho M
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26561230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.